ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BHVN vs HCM // 10Y YIELD & FRED MACRO BETA

Biohaven Ltd. (NYSE) VS. HUTCHMED (China) Limited (NASDAQ) • 15-METRIC TALLY: BHVN 2 — HCM 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BHVN VS. HCM) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BHVN HCM SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -2.50% -32.50 HCM /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -24.50% -3.32% -21.18 HCM /fcf-yield <GO>
Operating Margin — -7.10% — TIE /operating-margins <GO>
Net Profit Margin — 68.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — -13.00% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 3.63 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 4/9 -1.00 HCM /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 58.4 42.4 +16.00 BHVN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 4.8x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.33B $2.29B $35.1M BHVN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BHVN REV HCM REV BHVN GROSS % HCM GROSS % BHVN FCF HCM FCF
FY 2025 $2.09B $548.5M — 38.7% -$610.2M -$78.8M
FY 2024 $2.48B $630.2M — 44.6% -$586.5M -$17.4M
FY 2023 $1.22B $838.0M — — -$331.7M $219.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BHVN // BETA —
HCM // BETA —